Priyamvada Rai, Ph.D.
Affiliations: | 2003 | University of California, Berkeley, Berkeley, CA, United States |
Area:
Biophysical Chemistry: Proteins, Nucleic Acids, NMR SpectroscopyGoogle:
"Priyamvada Rai"Mean distance: 9.56
Parents
Sign in to add mentor| David E. Wemmer | grad student | 2003 | UC Berkeley | |
| (Part I. NMR studies of sequence-specific transition metal binding to biologically important DNA sequences cleaved during the iron-mediated Fenton reaction. Part II. DNA sequence-dependent steady-state and time-resolved fluorescence characteristics of 2-) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang L, Misiara L, Samaranayake GJ, et al. (2021) OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1. Redox Biology. 40: 101848 |
| Samaranayake GJ, Troccoli CI, Zhang L, et al. (2019) The existence of MTH1-independent 8-oxodGTPase activity in cancer cells as a compensatory mechanism against on-target effects of MTH1 inhibitors. Molecular Cancer Therapeutics |
| McPherson LA, Troccoli CI, Ji D, et al. (2019) Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. Dna Repair. 102644 |
| Zhu Y, Liu J, Park J, et al. (2019) Subcellular compartmentalization of NAD and its role in cancer: A sereNADe of metabolic melodies. Pharmacology & Therapeutics |
| Rai P, Sobol RW. (2019) Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage. Dna Repair. 77: 18-26 |
| Nagathihalli NS, Castellanos J, Lamichhane P, et al. (2018) Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. Cancer Research |
| Samaranayake GJ, Troccoli CI, Huynh MQ, et al. (2018) Abstract B032: Inappropriate AR reactivation-induced redox stress as a novel therapeutic target in castration-resistant prostate cancer Cancer Research. 78 |
| Troccoli C, Lyles R, Samaranayake G, et al. (2018) The ROS duality in castration-resistant prostate cancer emergence and progression Free Radical Biology and Medicine. 128: S75 |
| Rai P. (2018) Towards a better understanding of human MutT Homolog 1 (MTH1) as a therapeutic target in cancer Free Radical Biology and Medicine. 128 |
| Samaranayake GJ, Troccoli CI, Huynh M, et al. (2017) Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer. Nature Communications. 8: 1204 |